(Q24675002)

English

Randomized, open-label, comparative study of piperacillin-tazobactam administered by continuous infusion versus intermittent infusion for treatment of hospitalized patients with complicated intra-abdominal infection

scientific article

In more languages

Statements

scholarly article

0 references

Randomized, open-label, comparative study of piperacillin-tazobactam administered by continuous infusion versus intermittent infusion for treatment of hospitalized patients with complicated intra-abdominal infection (English)

0 references

hospitalization

1 reference

based on heuristic

inferred from title

5

object named as

Joseph L Kuti

0 references

David P Nicolau

4

object named as

David P Nicolau

0 references

author name string

William K Lau

1

0 references

David Mercer

2

0 references

Kamal M Itani

3

0 references

Debra Mansfield

6

0 references

Adrian Dana

7

0 references

language of work or name

0 references

publication date

November 2006

0 references

Antimicrobial Agents and Chemotherapy

0 references

50

0 references

11

0 references

3556-61

0 references

Optimization of meropenem minimum concentration/MIC ratio to suppress in vitro resistance of Pseudomonas aeruginosa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1635208

28 September 2017

Ceftazidime in acute myeloid leukemia patients with febrile neutropenia: helpfulness of continuous intravenous infusion in maximizing pharmacodynamic exposure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1635208

28 September 2017

Pharmacokinetics of piperacillin-tazobactam: intermittent dosing versus continuous infusion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1635208

28 September 2017

Clinical efficacy and pharmacoeconomics of a continuous-infusion piperacillin-tazobactam program in a large community teaching hospital

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1635208

28 September 2017

Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1635208

28 September 2017

Continuous infusion of ceftazidime in febrile neutropenic patients with acute myeloid leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1635208

28 September 2017

Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1635208

28 September 2017

Continuous infusion of beta-lactam antibiotics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1635208

28 September 2017

A randomized study of carbenicillin plus cefamandole or tobramycin in the treatment of febrile episodes in cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1635208

28 September 2017

Pharmacokinetics and pharmacodynamics of cefepime administered by intermittent and continuous infusion.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1635208

30 May 2018

Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1635208

30 May 2018

Population pharmacokinetics and pharmacodynamics of piperacillin/tazobactam in patients with complicated intra-abdominal infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1635208

28 November 2018

Continuous infusion of ticarcillin-clavulanate for home treatment of serious infections: clinical efficacy, safety, pharmacokinetics and pharmacodynamics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1635208

28 November 2018

Cost analysis of continuous versus intermittent infusion of piperacillin-tazobactam: a time-motion study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1635208

28 November 2018

Pharmacokinetics and pharmacodynamics of piperacillin/tazobactam when administered by continuous infusion and intermittent dosing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1635208

28 November 2018

Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1635208

28 November 2018

Cost-effectiveness of ceftazidime by continuous infusion versus intermittent infusion for nosocomial pneumonia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1635208

28 November 2018

Pharmacodynamics of intermittent- and continuous-infusion cefepime alone and in combination with once-daily tobramycin against Pseudomonas aeruginosa in an in vitro infection model.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1635208

28 November 2018

Pharmacoeconomics of continuous versus intermittent infusion of piperacillin-tazobactam for the treatment of complicated intraabdominal infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/16940077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Continuous infusion of ceftazidime in cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16940077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infusion phlebitis: relative incidence associated with cefuroxime administered by intermittent and continuous infusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/16940077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cure of Pseudomonas aeruginosa infection in neutropenic patients by continuous infusion of ceftazidime

1 reference

https://pubmed.ncbi.nlm.nih.gov/16940077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pharmacodynamics of beta-lactams

1 reference

https://pubmed.ncbi.nlm.nih.gov/16940077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost comparison of single daily i.v. doses of ceftriaxone versus continuous infusion of cefotaxime

1 reference

https://pubmed.ncbi.nlm.nih.gov/16940077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Continuous infusion of ceftazidime in cystic fibrosis patients during home treatment: clinical outcome, microbiology and pharmacokinetics

1 reference

https://pubmed.ncbi.nlm.nih.gov/16940077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of continuous versus intermittent administration of penicillin G in Streptococcus pneumoniae pneumonia in normal and immunodeficient rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/16940077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24675002&oldid=2144418599"